Announcements Trials
Browse Landscape

Phase

Phase 2 117Phase 1 99Phase 1/2 50Phase NA 46Phase 3 22Phase EARLY_PHASE1 9Phase 2/3 5Phase 4 4

Status

Completed 20Unknown 13Terminated 4Recruiting 3Withdrawn 2Not yet recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Head & Neck 1

Conditions

Breast Neoplasms 18Neoplasms 16Prostatic Neoplasms 12Neoplasm Metastasis 10Pain 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Polycystic Ovary Syndrome 7Leiomyoma 6Anemia 5Skin Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Carcinoma, Renal Cell 4Recurrence 3Melanoma 3Liver Neoplasms 3Kidney Neoplasms 3Keratosis, Actinic 3Insulin Resistance 3Carcinoma, Hepatocellular 3Cancer Pain 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2

Interventions

Pregabalin 1Pancrelipase 1Mirtazapine 1Gemcitabine 1Erlotinib Hydrochloride 1Dronabinol 1Diet Therapy 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Pancreatic Neoplasms × Clear all
NCT03859869 2023-06-05

A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)

AbbVie

Phase 4 Terminated
1 enrolled 6 charts
Gastrointestinal

Exocrine Pancreatic Insufficiency, Pancreatic Neoplasms

NCT04155008 2022-11-16

Nutrition and Pharmacological Algorithm for Oncology Patients Study

Montefiore Medical Center

Phase 4 Terminated
1 enrolled 5 charts
GastrointestinalHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Malnutrition

NCT01768988 2017-10-06

PANPAIN/1

Parc de Salut Mar

Phase 4 Terminated
20 enrolled
Gastrointestinal

Pancreatic Neoplasms, Visceral Pain

NCT00642733 2016-08-24

A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Hoffmann-La Roche

Phase 4 Terminated
6 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡